Acupuncture Combined With Yanqing Zhitong Ointment Acupoint Application in Chronic Non-specific Low Back Pain
Unknown statusNot applicableNCT05040243
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Carry out a randomized controlled double-blind study, the acupuncture combined with placebo application group was compared with the acupuncture combined with Yanqing Zhitong ointment acupoint application group, 86 patients with chronic non-specific low back pain were included.
Study details
- Official title
- A Randomized Controlled Double-blind Study of Acupuncture Combined With Yanqing Zhitong Ointment Acupoint Application in the Treatment of Chronic Non-specific Low Back Pain
- Conditions
- Non-specific Low Back Pain
- Interventions
- Other: Yanqing Zhitong Ointment Acupoint application
- Other: placebo acupoint application
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start date
- 2021-07-01
- Primary completion
- 2022-12-30
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Diagnostic of non-specific low back pain 2. Aage from 18 to 65 3. Last for at least 12 weeks 4. VAS between 4 and 7 5. No other treatment in the past 3 months 6. Patients with no partial skin damage 7. No other relevant treatment methods 8. Sign informed consent and informed consent Exclusion Criteria: 1. Pregnant women 2. Suffer from diabetes 3. With skin ulcers or contusion wounds 4. Past history of severe allergy to transdermal preparations 5. Complicated with serious diseases
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05040243